Research News and Research

RSS

Democrats weigh impact of election results on health reform

While some Democrats seem rattled by election results this week, others say the GOP victories in two races for governor won't change their approach to health overhaul legislation.

5 Nov 2009

Cadence Pharmaceuticals reports net loss of $11.4 million for three months ended September 30, 2009

Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial results for the three and nine months ended September 30, 2009.

5 Nov 2009

CBO: GOP health bill would cut deficit somewhat, do little to expand coverage

"The Congressional Budget Office said Wednesday that the alternative health care bill proposed by House Republicans would have little impact in extending health benefits to the roughly 30 million uninsured Americans, but would reduce average insurance premium costs for people who have coverage," The New York Times reports.

5 Nov 2009

AARP, key retirees' lobby, to endorse Democrats' health bill

AARP, the influential retirees' lobby, is expected to endorse House Democrats' plan to overhaul the health system today, the Associated Press reports, citing unnamed officials. "Backing the 10-year, $1.2 trillion House bill is a tricky move for AARP.

5 Nov 2009

Climate change is biggest global health threat to children, report says

According to a report (.pdf) by Save the Children, climate change is the biggest global health threat to children in the 21st century, the Hindu reports. Save the Children says that climate change will "exacerbate the leading causes of death among children, including diarrhoea, malnutrition and malaria. Diarrhoea, which kills one million children every year, is set to increase by 10 percent by 2020.

5 Nov 2009

Health overhaul outlook: Could delays jeopardize the reform effort?

Kaiser Health News staff writers Mary Agnes Carey and Eric Pianin report on whether current timeline slips may or may not undermine health reform's chances. "Passing a health care overhaul bill might be one of the hardest things Congress has ever attempted. But waiting until next year might jeopardize a top priority for President Barack Obama and Democrats in Congress.

5 Nov 2009

Re-classification of cannabis will have minimal impact on incidence of psychosis says study

The research follows last year’s decision by the UK government to reclassify the drug from class C to class B, partly out of concerns that cannabis, especially the more potent varieties, may increase the risk of schizophrenia in young people. However, the evidence for the relationship between cannabis and schizophrenia or psychosis remains controversial.

5 Nov 2009

Nanoparticles may cause DNA damage across a cellular barrier

Scientists have shown in the laboratory that metal nanoparticles damaged the DNA in cells on the other side of a cellular barrier. The nanoparticles did not cause the damage by passing through the barrier, but generated signalling molecules within the barrier cells that were then transmitted to cause damage in cells the other side of the barrier.

5 Nov 2009

ARIAD Pharmaceuticals' SUCCEED trial of oral ridaforolimus on track

ARIAD Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009 and provided an update on corporate developments.

5 Nov 2009

New biosensor device may help in combating cancer

A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use. Enlisting the patient's own immune system would be like sending reinforcements for resistance fighters.

5 Nov 2009

Oncolytics Biotech reports financial results for the third quarter of 2009

Oncolytics Biotech Inc. today announced its financial results for the three and nine-month periods ended September 30, 2009.

5 Nov 2009

LaserBand signs an agreement for healthcare wristbands and labels with MedAssets Supply Chain Systems

LaserBand, the leading provider of patient identification wristbands and related products, recently signed an agreement for healthcare wristbands and labels with MedAssets Supply Chain Systems, one of the nation’s largest group purchasing organizations (GPO).

5 Nov 2009

Home Diagnostics announces financial results for third quarter 2009; reports decreased gross margin

Home Diagnostics, Inc. (Nasdaq:HDIX), a leading manufacturer and marketer of diabetes testing supplies, today announced financial results for the third quarter ended September 30, 2009.

5 Nov 2009

I-Flow reports financial results for the third quarter of 2009

I-FLOW CORPORATION announced today that total revenue for the third quarter ended September 30, 2009 increased 14% to $36.7 million compared to total revenue of $32.2 million for the third quarter of 2008.

5 Nov 2009

Third-quarter financial results for the year 2009 announced by Biovail

Biovail Corporation today announced financial results for the three-month and nine-month periods ended September 30, 2009. To the extent that this news release contains forward-looking statements, investors are cautioned that these statements are based on the Company’s current views, and actual outcomes are not certain.

5 Nov 2009

ArQule reports financial results for the fiscal quarter and nine months ended September 30, 2009

ArQule, Inc. today reported its results of operations for the fiscal quarter and nine months ended September 30, 2009.

5 Nov 2009

Idera Pharmaceuticals announces financial results for the third quarter of 2009

Idera Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009.

5 Nov 2009

Inspire Pharmaceuticals reports net loss of $8.5 million for the third quarter ended September 30, 2009

Inspire Pharmaceuticals, Inc. announced today financial results for the third quarter ended September 30, 2009, reporting a net loss of $8.5 million or ($0.12) per common share.

5 Nov 2009

FDA approves the New Drug Application for Pennsaid Topical Solution

Covidien, a leading global provider of healthcare products, and Nuvo Research Inc., a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid(R) Topical Solution (diclofenac sodium topical solution) 1.5% w/w.

5 Nov 2009

Second-quarter fiscal 2010 results announced by Repligen

Repligen Corporation today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the quarter was $5,421,000 compared to total revenue of $5,090,000 for the second quarter of fiscal year 2009 ended September 30, 2008.

5 Nov 2009